Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Simbolo

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Virchows Archiv : an International Journal of Pathology|May 16, 2014
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomasMichele Simbolo, Caterina Mian, Susi Barollo, et al.
JTO Clinical and Research Reports|December 21, 2023
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case ReportMarco Sposito, Ilaria Mariangela Scaglione, Serena Eccher, et al.
Pathology, Research and Practice|July 16, 2023
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroupsPaola Mattiolo, Anastasios Gkountakos, Giovanni Centonze, et al.
Oncotarget|January 9, 2016
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencingAndrea Mafficini, Michele Simbolo, Alice Parisi, et al.
Pathologica|April 28, 2022
Metastasis of lung carcinoid in the thyroid gland after 18 years: it is never too late. A case report and review of the literatureMichele Dello Spedale Venti, Elisa Giannetta, Daniela Bosco, et al.
Targeted Oncology|September 1, 2018
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
Acta Neuropathologica Communications|December 25, 2021
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutationValeria Barresi, Michele Simbolo, Andrea Mafficini, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigmGiuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, et al.
Pathology, Research and Practice|September 8, 2018
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistanceCaterina Vicentini, Cinzia Cantù, Davide Antonello, et al.
Cancers|March 11, 2023
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and TreatmentAnastasios Gkountakos, Filippo M Martelli, Nicola Silvestris, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Virchows Archiv : an International Journal of Pathology|May 16, 2014
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomasMichele Simbolo, Caterina Mian, Susi Barollo, et al.
JTO Clinical and Research Reports|December 21, 2023
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case ReportMarco Sposito, Ilaria Mariangela Scaglione, Serena Eccher, et al.
Pathology, Research and Practice|July 16, 2023
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroupsPaola Mattiolo, Anastasios Gkountakos, Giovanni Centonze, et al.
Oncotarget|January 9, 2016
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencingAndrea Mafficini, Michele Simbolo, Alice Parisi, et al.
Pathologica|April 28, 2022
Metastasis of lung carcinoid in the thyroid gland after 18 years: it is never too late. A case report and review of the literatureMichele Dello Spedale Venti, Elisa Giannetta, Daniela Bosco, et al.
Targeted Oncology|September 1, 2018
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
Acta Neuropathologica Communications|December 25, 2021
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutationValeria Barresi, Michele Simbolo, Andrea Mafficini, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2018
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigmGiuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, et al.
Pathology, Research and Practice|September 8, 2018
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistanceCaterina Vicentini, Cinzia Cantù, Davide Antonello, et al.
Cancers|March 11, 2023
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and TreatmentAnastasios Gkountakos, Filippo M Martelli, Nicola Silvestris, et al.
Pageof 9